p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
about
Chemical Variations on the p53 Reactivation ThemeSubchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogsRNA therapeutics targeting osteoclast-mediated excessive bone resorption.IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis.P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.
P2860
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@en
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@nl
type
label
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@en
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@nl
prefLabel
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@en
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@nl
P2860
P1476
p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
@en
P2093
Crispin R Dass
Soo-Hyun Kim
P2860
P304
P356
10.1111/J.2042-7158.2010.01248.X
P577
2011-03-31T00:00:00Z